Fujirebio is an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Fujirebios mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. The global teams located in Japan, Asia, Europe and the US focus on delivering products with the highest quality standards to customers and partners.
Fujirebio value partnerships with other leading companies in the industry, sharing knowledge, capabilities, and critical materials in order to supply, develop or manufacture diagnostic solutions on a wide variety of platforms. Through this business model, they ensure that the potentially life-changing diagnostic markers meet the largest global need in the shortest possible time.
New HQ for cancer diagnostic-company Fujirebio Diagnostics
Completed in Q3 2021
8 000 m2 Established Today